CA1148455A - SUBSTRATE FOR THE DETECTION OF THE .delta.-GLUTAMYLTRANSPEPTIDASE - Google Patents
SUBSTRATE FOR THE DETECTION OF THE .delta.-GLUTAMYLTRANSPEPTIDASEInfo
- Publication number
- CA1148455A CA1148455A CA000351131A CA351131A CA1148455A CA 1148455 A CA1148455 A CA 1148455A CA 000351131 A CA000351131 A CA 000351131A CA 351131 A CA351131 A CA 351131A CA 1148455 A CA1148455 A CA 1148455A
- Authority
- CA
- Canada
- Prior art keywords
- substrate
- acid
- nitranilide
- glutamyl
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 27
- 238000001514 detection method Methods 0.000 title claims abstract description 6
- 239000002253 acid Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003599 detergent Substances 0.000 claims description 5
- 150000003863 ammonium salts Chemical class 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 3
- 150000002989 phenols Chemical class 0.000 claims description 2
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 claims 1
- 239000012085 test solution Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 208000019423 liver disease Diseases 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- -1 di- Chemical class 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 3
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cephalosporin Compounds (AREA)
Abstract
SUBSTRATE FOR THE DETECTION OF THE ?-GLUTAMYLTRANSPEPTIDASE
Abstract of the disclosure:
A substrate suitable for the detection of the ?-glu-tamyltranspeptidase in aqueous systems is described. It can be used for the diagnosis of liver diseases and for assessing the course of such diseases.
Abstract of the disclosure:
A substrate suitable for the detection of the ?-glu-tamyltranspeptidase in aqueous systems is described. It can be used for the diagnosis of liver diseases and for assessing the course of such diseases.
Description
; -
2 ~ Jk~5 ~ HOE 79/B 005 The present invention relates to a substrate for thedetection of the ~glutamyltranspeptidase in aqueous systems, in particular in biological fluids, especially in blood se-rum. It is used mainly for the diagnosis of liver diseases and for assessing the course of these diseases.
The ~-glutamyltranspeptidase ( ~-GT)-activity may be determined according to the following known reaction scheme:
2~-glutamyl-p-nitranilide + glycylglycin ~;;;=~ p-nitra-niline + glutamylglycylglycin.
10 The release of the yellow-colored p-nitraniline can be ob-served optically. The change in optical density relates to the 2~-GT activity in the test sample.
This way of detecting ~-GT enzyme activity is rather simple. It has, however, the disadvantage that the substrate 15 ~-glutamyl-p-nitranilide has a very low solubility in aqueous solutions at pH values that have to be maintained in the test tube during the determination of the ~-GT. This is known inter alia from the patent applications DE-OS
2,042,829 published March 16, 1972 and DE-OS 2,259,512 published 20 June 27, 1974. Several trials have been made to solve this problem. For exaTrple, the substrate has been dissolved in dilute hydrochloric acid or in organic solvents in a high concentration and the resulting solution has been added in low quantities to the mixtures to be analyzed, thus preventing a significan. displacement of the pH value in the 25 test tube. However, this method is rather complicated and the substrate is not very stable in highly acidic, aqueous media. Therefore solutions of this type can be used for measurement only within a short period of time.
A further known process comprises dissolving the ~glu-30 tamyl-p-nitranilide at a temperature of 50 to 60C and cooling the resulting solution subsequently to room tempe-rature. This method, too, involves the danger of a sponta-neous hydrolysis of the chromophoric group.
Moreover this procedure is time-consuming and even 35 fails sometimes because of recrystallization of the sub-strate. These methods are unsatisfactory for a routine app-lication of the test in clinical laboratories. It was the-refore a task to surmount the above~mentioned disadvantages .
.
. . :
~ , , .
.
The ~-glutamyltranspeptidase ( ~-GT)-activity may be determined according to the following known reaction scheme:
2~-glutamyl-p-nitranilide + glycylglycin ~;;;=~ p-nitra-niline + glutamylglycylglycin.
10 The release of the yellow-colored p-nitraniline can be ob-served optically. The change in optical density relates to the 2~-GT activity in the test sample.
This way of detecting ~-GT enzyme activity is rather simple. It has, however, the disadvantage that the substrate 15 ~-glutamyl-p-nitranilide has a very low solubility in aqueous solutions at pH values that have to be maintained in the test tube during the determination of the ~-GT. This is known inter alia from the patent applications DE-OS
2,042,829 published March 16, 1972 and DE-OS 2,259,512 published 20 June 27, 1974. Several trials have been made to solve this problem. For exaTrple, the substrate has been dissolved in dilute hydrochloric acid or in organic solvents in a high concentration and the resulting solution has been added in low quantities to the mixtures to be analyzed, thus preventing a significan. displacement of the pH value in the 25 test tube. However, this method is rather complicated and the substrate is not very stable in highly acidic, aqueous media. Therefore solutions of this type can be used for measurement only within a short period of time.
A further known process comprises dissolving the ~glu-30 tamyl-p-nitranilide at a temperature of 50 to 60C and cooling the resulting solution subsequently to room tempe-rature. This method, too, involves the danger of a sponta-neous hydrolysis of the chromophoric group.
Moreover this procedure is time-consuming and even 35 fails sometimes because of recrystallization of the sub-strate. These methods are unsatisfactory for a routine app-lication of the test in clinical laboratories. It was the-refore a task to surmount the above~mentioned disadvantages .
.
. . :
~ , , .
.
- 3 - HOE 79/B 005 and to provide a 3 glutamyl-p-nitranilide substrate 'chat is sufficiently soluble in the buffer solution at a temperatu-re of approximately 25C, which is necessary for carrying out the determination.
It has now been found surprisingly according to the invention that dry Y~-glutamyl p-nitranilide, preferably in lyophilized form, dissolves instantaneously in the test buf-fer at 20 to 25C, if the substrate is present in protoniz-ed form, that means, as a salt. Consequently, an acid has to be added to the ~-glutamyl-p-nitranilide prior to drying, in a stoichiometrical ratio or in an excess, relative to the base equivalents.
The subject of the present invention is therefore a dry and well soluble preparation of the ~-glutamyl-p-nitranilide ~5 substrate suitable for the detection of the t'-GT, containing at least one equivalent of an acid per base equivalent of the substrate.
It has moreover been found that the reagent, u?on re-dissolution, is distinguished by a higher color stability, if a quaternary polycation is present in the substrate so-lution. The dry preparation therefore comprises, if appro priate, a high molecular weight detergent which is a fur-ther feature of the subject of the present invention.
In the narrow sense it is an object of the present in-ven~ion to use the ammonium salt of the ~-glutamyl-p-ni-tranilide as a substrate optionally with an excess of an acid for the detection of ~-glutamyltranspeptidase.
Suitable acids for this purpose are nearly all organic or inorganic acids, that are able of forming an ammonium salt with the ~-glutamyl-p-nitranilide. Examples of these acids are : sulfuric acid, phosphoric acids, all hydrohalic acids, oxyhydrohalic acids, acetic acid and trifluoroacetic acid. Combinations of an i.norganic and an organic acid such as di-, tri- and tetra-carboxylic acids or hydroxycarboxylic acids, for example malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, maleic acid, fumaric acid, malic acid, tartaric acid, citric acld, ascorbic acid, glu-curonic acid, have pro~ed advantageous. A combination of `
,~
' ' . ' '~. ` ' :
~, _ 1~ _ HOE 79/B_005 an inorganic acid, for example hydrochloric acid and an or-ganic acid, for example tartaric acid, is used preferably.
A ratio of about 0.9 equivalent of the inorganic acid to about 0.1 e~uivalent of the organic acid, relative to the base equivalent of the nitranilide, is particularly suitable.
Any chemical methods~suitable for the preparation of an ammonium salt from the primary amine may be used for preparing the substrate. An excess of acid is not detrimen-tal as far as the substrate can be lyophilized conveniently and the redissolved substrate does not exceed the bu~fer capacity of the test buffer. According to a very simple method of preparing the substrate, an aqueous solution of the ~-glutamyl-p-nitranilide is used as starting product.
Subsequently the stoichiometrical ratio of the anilide to an acid is determined, the appropriate acid is added to the solution so as to obtain the desired ratio, optionally in an excess of about 20 ~ and the resulting product is dried, preferably by lyophilization.
A further simple way to obtain a preparation according to the invention consists in acidifying the aqueous solution of the nitranilide with the appropriate acid prior to dry-ing.
The essential advantage of the dry product according to the invention is to be seen in the fact that no signifi-cant hydrolysis occurs prior to its application in the testand that the test is not impaired by high blank values.
As mentioned above, the substrate properties are im-proved by adding to the substrate solution a quaternary polycation in a concentration range between 0.1 and 100 mg/l. These findings are surprising, for it is known that conventional cationic or anionic detergents inhibit or reduce the ~-glutamyltranspeptidase activity. However, polycations derived from polyvinylpyrrolidone have no detectable influence on the ~T-activity. Ethoxylated alkylphenols or ethoxylated phenols as well as tetrafluor-ethylene polymers having branched perfluoro groups act in analogous manner. These polymers, used alone or in combina~
tions, have a retarding effect on the recrystalization of .
' ~ .
- 5 - HOE _~/P, 005 the ~ ~lutamyl-p l~itranllide at room temperature.
For the convenience of the user the salt of the ~-glu-tamyl-p-nitranilide, to which the polymer has been added optionally, may be present in the test kit in solid form, for example as a dry powder or in tableted form.
The stability o~ ~le ~xduct ~lmo~e~verbe:~,proved by add-ing compounds to the lyophili~ation solution such as gelatin or gelatin hydrolysates, sugar alcohols or carbohydrates, buffer components, preservation agents and/or compounds promoting dissolution. In a preferred embodiment mannitol is used in a concentration range between 1 and 50 mg/ml.
The glycylglycin participating in the reaction of the transpeptidase may be likewise present in the dry prepara-tion. To perform the ~GT-determination, the dry substrate mixture has simply to be dissolved in water.
The following example illustrates the invention:
Example The substrate according to the invention is prepared in the following manner:
a) Substrate components:
1~ 1.17 g of ~-glutamyl-p-nitranilide (1.176 g/1000 ml = 4.4 mM), 2) 8.7 g of glycylglycin, 3) 16 g of mannitol,
It has now been found surprisingly according to the invention that dry Y~-glutamyl p-nitranilide, preferably in lyophilized form, dissolves instantaneously in the test buf-fer at 20 to 25C, if the substrate is present in protoniz-ed form, that means, as a salt. Consequently, an acid has to be added to the ~-glutamyl-p-nitranilide prior to drying, in a stoichiometrical ratio or in an excess, relative to the base equivalents.
The subject of the present invention is therefore a dry and well soluble preparation of the ~-glutamyl-p-nitranilide ~5 substrate suitable for the detection of the t'-GT, containing at least one equivalent of an acid per base equivalent of the substrate.
It has moreover been found that the reagent, u?on re-dissolution, is distinguished by a higher color stability, if a quaternary polycation is present in the substrate so-lution. The dry preparation therefore comprises, if appro priate, a high molecular weight detergent which is a fur-ther feature of the subject of the present invention.
In the narrow sense it is an object of the present in-ven~ion to use the ammonium salt of the ~-glutamyl-p-ni-tranilide as a substrate optionally with an excess of an acid for the detection of ~-glutamyltranspeptidase.
Suitable acids for this purpose are nearly all organic or inorganic acids, that are able of forming an ammonium salt with the ~-glutamyl-p-nitranilide. Examples of these acids are : sulfuric acid, phosphoric acids, all hydrohalic acids, oxyhydrohalic acids, acetic acid and trifluoroacetic acid. Combinations of an i.norganic and an organic acid such as di-, tri- and tetra-carboxylic acids or hydroxycarboxylic acids, for example malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, maleic acid, fumaric acid, malic acid, tartaric acid, citric acld, ascorbic acid, glu-curonic acid, have pro~ed advantageous. A combination of `
,~
' ' . ' '~. ` ' :
~, _ 1~ _ HOE 79/B_005 an inorganic acid, for example hydrochloric acid and an or-ganic acid, for example tartaric acid, is used preferably.
A ratio of about 0.9 equivalent of the inorganic acid to about 0.1 e~uivalent of the organic acid, relative to the base equivalent of the nitranilide, is particularly suitable.
Any chemical methods~suitable for the preparation of an ammonium salt from the primary amine may be used for preparing the substrate. An excess of acid is not detrimen-tal as far as the substrate can be lyophilized conveniently and the redissolved substrate does not exceed the bu~fer capacity of the test buffer. According to a very simple method of preparing the substrate, an aqueous solution of the ~-glutamyl-p-nitranilide is used as starting product.
Subsequently the stoichiometrical ratio of the anilide to an acid is determined, the appropriate acid is added to the solution so as to obtain the desired ratio, optionally in an excess of about 20 ~ and the resulting product is dried, preferably by lyophilization.
A further simple way to obtain a preparation according to the invention consists in acidifying the aqueous solution of the nitranilide with the appropriate acid prior to dry-ing.
The essential advantage of the dry product according to the invention is to be seen in the fact that no signifi-cant hydrolysis occurs prior to its application in the testand that the test is not impaired by high blank values.
As mentioned above, the substrate properties are im-proved by adding to the substrate solution a quaternary polycation in a concentration range between 0.1 and 100 mg/l. These findings are surprising, for it is known that conventional cationic or anionic detergents inhibit or reduce the ~-glutamyltranspeptidase activity. However, polycations derived from polyvinylpyrrolidone have no detectable influence on the ~T-activity. Ethoxylated alkylphenols or ethoxylated phenols as well as tetrafluor-ethylene polymers having branched perfluoro groups act in analogous manner. These polymers, used alone or in combina~
tions, have a retarding effect on the recrystalization of .
' ~ .
- 5 - HOE _~/P, 005 the ~ ~lutamyl-p l~itranllide at room temperature.
For the convenience of the user the salt of the ~-glu-tamyl-p-nitranilide, to which the polymer has been added optionally, may be present in the test kit in solid form, for example as a dry powder or in tableted form.
The stability o~ ~le ~xduct ~lmo~e~verbe:~,proved by add-ing compounds to the lyophili~ation solution such as gelatin or gelatin hydrolysates, sugar alcohols or carbohydrates, buffer components, preservation agents and/or compounds promoting dissolution. In a preferred embodiment mannitol is used in a concentration range between 1 and 50 mg/ml.
The glycylglycin participating in the reaction of the transpeptidase may be likewise present in the dry prepara-tion. To perform the ~GT-determination, the dry substrate mixture has simply to be dissolved in water.
The following example illustrates the invention:
Example The substrate according to the invention is prepared in the following manner:
a) Substrate components:
1~ 1.17 g of ~-glutamyl-p-nitranilide (1.176 g/1000 ml = 4.4 mM), 2) 8.7 g of glycylglycin, 3) 16 g of mannitol,
4) 10 g of potassium-sodium tartrate . 4 H20,
5) 40 g of quaternary polyamine,
6) 2 N HCl
7~ distilled water.
Gomponents 1 to 5 are dissolved in about 600 to 700 ml of distilled water and heated to about 40C. Component 6 is added until a pH value between 3 and 4 is reached.
After complete dissolution of all substrate components the solution is cooled to about 20C and the pH is adjusted ` to 2 to 3 with 2 N HCl. Distilled water (7) is added up to a volume of 1 liter.
Suitably the ~ glutamyltranspepti.dase is determined by using 2 ml of this substrate solution. Therefore the~ solu-tion is dispensed to vial5 in portions of 2 ml, which are . -., , lyophilized. To perform the test the lyophilized product is redissolved with the buffer solution b).
b) buffer solution ...... _
Gomponents 1 to 5 are dissolved in about 600 to 700 ml of distilled water and heated to about 40C. Component 6 is added until a pH value between 3 and 4 is reached.
After complete dissolution of all substrate components the solution is cooled to about 20C and the pH is adjusted ` to 2 to 3 with 2 N HCl. Distilled water (7) is added up to a volume of 1 liter.
Suitably the ~ glutamyltranspepti.dase is determined by using 2 ml of this substrate solution. Therefore the~ solu-tion is dispensed to vial5 in portions of 2 ml, which are . -., , lyophilized. To perform the test the lyophilized product is redissolved with the buffer solution b).
b) buffer solution ...... _
8) 24 g of tris-(hydroxymethyl) aminomethane and
9) 5 g of sodium azide are dissolved in about 800 ml of distilled water, the pH is adjusted to 9.2 - 9.5 with 2 N HCl and distilled water is ad-ded up to a volume of 1.0 liter. A pH value of about 8.2 will result, if 2 ml of buffer solution of the above compo-sition are added to the lyophilized substrate mixture ac-cording to a).
. . ~ . ,.. ~ . _ ., , .. _ .. . .
,
. . ~ . ,.. ~ . _ ., , .. _ .. . .
,
Claims (5)
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A dry preparatin of ?-glutamyl-p-nitranilide for use as a substrate for the detection of ?-glutamyl-transpeptidase, con-taining an acid in an at least molar ratio, relative to the base equivalent of the nitranilide.
2. A dry preparation as claimed in claim 1 which also con-tains a detergent.
3. A dry preparation as claimed in claim 2 in which the detergent is a quaternary polycation based on polyvinylpyrrolidine or an ethoxylated alkylphenol, an ethoxylated phenol or a tetra-fluoroethylene polymer having branched perfluoro alkyl groups.
4. A dry preparation as claimed in claim 2 or claim 3 in which the detergent is present in a concentration ranging from 0.1 to 100 mg/ml of test solution.
5. A dry preparation as claimed in claim 1, claim 2 or claim 3 in which the acid is selected from the group of organic or inorganic acids capable of forming an ammonium salt with ?-glutamyl-p-nitranilide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792917999 DE2917999A1 (en) | 1979-05-04 | 1979-05-04 | SUBSTRATE FOR DETERMINING THE GAMA GLUTAMYL TRANSPEPTIDASE |
DEP2917999.5 | 1979-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1148455A true CA1148455A (en) | 1983-06-21 |
Family
ID=6069919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000351131A Expired CA1148455A (en) | 1979-05-04 | 1980-05-02 | SUBSTRATE FOR THE DETECTION OF THE .delta.-GLUTAMYLTRANSPEPTIDASE |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0018628B1 (en) |
JP (1) | JPS55153600A (en) |
AT (1) | ATE7049T1 (en) |
AU (1) | AU544691B2 (en) |
CA (1) | CA1148455A (en) |
DE (2) | DE2917999A1 (en) |
ES (1) | ES490961A0 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53147034A (en) * | 1977-05-30 | 1978-12-21 | Wako Pure Chem Ind Ltd | Gamma-glutamyl-p-aminoanilide derivatives and process for their preparation |
US4511651A (en) * | 1982-07-30 | 1985-04-16 | American Monitor Corporation | Reagent composition and assay for the determination of γ-glutamyltransferase activity |
EP0118534B1 (en) * | 1982-08-30 | 1987-04-08 | Beckman Instruments, Inc. | METHOD FOR DETERMINING $g(g)-GLUTAMYLTRANSFERASE ACTIVITY AND KITS CONTAINING A NOVEL SUBSTRATE SOLUTION FOR USE THEREIN |
US4588836A (en) * | 1982-09-01 | 1986-05-13 | Toyo Jozo Kabushiki Kaisha | Novel synthetic substrate and assay method using the same |
US4560650A (en) * | 1983-06-08 | 1985-12-24 | Coulter Electronics, Inc. | Method and compositions for determination of gamma glutamyl transpeptidase |
JP2501801B2 (en) * | 1986-10-07 | 1996-05-29 | ユニチカ株式会社 | Reagent for quantifying γ-glutamyl transpeptidase |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4910718B1 (en) * | 1969-06-23 | 1974-03-12 | ||
AT308050B (en) * | 1970-08-28 | 1973-06-25 | Boehringer Mannheim Gmbh | Reagent for the determination of γ-glutamyl transpeptidase |
-
1979
- 1979-05-04 DE DE19792917999 patent/DE2917999A1/en not_active Withdrawn
-
1980
- 1980-04-28 ES ES490961A patent/ES490961A0/en active Granted
- 1980-04-30 EP EP80102321A patent/EP0018628B1/en not_active Expired
- 1980-04-30 AT AT80102321T patent/ATE7049T1/en not_active IP Right Cessation
- 1980-04-30 DE DE8080102321T patent/DE3067415D1/en not_active Expired
- 1980-05-02 CA CA000351131A patent/CA1148455A/en not_active Expired
- 1980-05-02 JP JP5804980A patent/JPS55153600A/en active Pending
- 1980-05-02 AU AU58032/80A patent/AU544691B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU5803280A (en) | 1980-11-06 |
DE3067415D1 (en) | 1984-05-17 |
EP0018628A1 (en) | 1980-11-12 |
AU544691B2 (en) | 1985-06-13 |
ES8102358A1 (en) | 1980-12-01 |
ES490961A0 (en) | 1980-12-01 |
DE2917999A1 (en) | 1980-11-13 |
ATE7049T1 (en) | 1984-04-15 |
JPS55153600A (en) | 1980-11-29 |
EP0018628B1 (en) | 1984-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kato et al. | An enzymatic cycling method for nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases | |
Brewer | Yeast enolase: mechanism of activation by metal ion | |
JPS6412343B2 (en) | ||
CA1148455A (en) | SUBSTRATE FOR THE DETECTION OF THE .delta.-GLUTAMYLTRANSPEPTIDASE | |
JP2002525123A (en) | How to detect ATP | |
CA1073328A (en) | Fluorimetric demonstration and determination of a reduced coenzyme or derivative in an aqueous system | |
CA1168609A (en) | Method of forming stabilized urease solutions | |
Schimerlik et al. | The pH variation of the kinetic parameters and the catalytic mechanism of malic enzyme | |
Yokoyama et al. | The reconstituted α3β3δ complex of the thermostable F1-ATPase | |
JP2796462B2 (en) | Ethanol analysis composition | |
US5162309A (en) | Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r,cis)-1,2-ep-oxipropyl-phosphonate with improved characteristics of stability and processing | |
US6432717B1 (en) | Stabilized test composition, device and method for the determination of cyanuric acid in water | |
JPH01108997A (en) | Method and reagent for particularly determining fructosamine content of serum in blood or specimen derived from blood,and method for removing specimen component causing nonspecific reductive action or/and suspension | |
Teipel et al. | The number of substrate-and inhibitor-binding sites of fumarase | |
EP0193204B1 (en) | Process for determining superoxide dismutase activity | |
Cuenda et al. | Distances between functional sites of the Ca2++ Mg2+‐ATPase from sarcoplasmic reticulum using Co2+ as a spectroscopic ruler | |
CN104195220B (en) | A kind of kit for human serum determining alanine aminopherase | |
US4072627A (en) | Uric acid determination | |
EP3178927A1 (en) | Protein-stabilizing agent and protein-stabilizing method | |
EP0513914A1 (en) | Stabilization of the enzyme urate oxidase in liquid form | |
EP0229094B1 (en) | Bacterial cell extractantand method of extracting a substance | |
FUJITA et al. | Application of o-Hydroxyhydroquinonephthalein-Iron (III): Complex to Determination of Organic Compounds Containing Phosphorus | |
JP2008206491A (en) | METHOD FOR STABILIZING p-HYDROXYBENZOATE HYDROXYLASE | |
EP0415471B1 (en) | Stabilized Trinder reagent | |
Dennis et al. | A method for determination of the synthesis rate of stable and unstable ribonucleic acid in Escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |